Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage
NCT07662174
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Post-hemorrhagic Hydrocephalus (PHH)
Interventions
DRUG:
Sirolimus (Rapamune®)
Sponsor
Massachusetts General Hospital